StockData
Lakewood-Amedex Biotherapeutics Inc. logo

Lakewood-Amedex Biotherapeutics Inc. (LABT) stock

LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$0.21−0.00 (-2.23%)

Close on Nov 17, 2026Market cap $508.30KP/E –Yield –

Lakewood-Amedex Biotherapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.26M–
Q2 FY2026Jun 30, 2026-$2.10M–
Q1 FY2026Mar 31, 2026-$349.69K–
Q3 FY2025Sep 30, 2025-$610.05K–
Q2 FY2025Jun 30, 2025-$508.55K–
Q1 FY2025Mar 31, 2025-$404.09K–

More Lakewood-Amedex Biotherapeutics figures

See a number that looks wrong?